Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Unicycive Therapeutics Inc (NQ: UNCY )

0.3874 +0.0074 (+1.95%)
Streaming Delayed Price Updated: 9:35 AM EDT, Sep 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 34,560
Open 0.3900
Bid (Size) 0.3850 (7)
Ask (Size) 0.3897 (1)
Prev. Close 0.3800
Today's Range 0.3874 - 0.3900
52wk Range 0.2020 - 1.818
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
UNCY Stock Earnings: Unicycive Therapeutics Beats EPS for Q2 2024
UNCY stock results show that Unicycive Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are a hot topic on Friday as we check out all of the stories affecting shares on the last day of trading this week! 
Via InvestorPlace

Performance

YTD
-56.26%
-56.26%
1 Month
+64.15%
+64.15%
3 Month
-40.85%
-40.85%
6 Month
-73.10%
-73.10%
1 Year
-45.81%
-45.81%

More News

Read More
Greenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Where Unicycive Therapeutics Stands With Analysts
Via Benzinga
Analyst Expectations for Unicycive Therapeutics's Future
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q1 2024
Via InvestorPlace
UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
The 7 Most Undervalued Penny Stocks to Buy in October 2023
Via InvestorPlace
Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight Series
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
CORRECTION FROM SOURCE: 60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
Via ACCESSWIRE
60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
Via ACCESSWIRE
Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Conference
From Unicycive Therapeutics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.